Showing results (41-50 of 79) with videos related to
Sort By:
Pageof 8
The Journal of Antimicrobial Chemotherapy|February 14, 1998
Comparison of dose doubling with probenecid for sustaining serum cefuroxime levelsA M Garton, R P Rennie, J Gilpin, et al.HIV Medicine|June 15, 2007
Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccineS D Shafran, L D Mashinter, A Lindemulder, et al.HIV Medicine|May 18, 2019
Planning HIV therapy to prevent future comorbidities: patient years for tenofovir alafenamideS D Shafran, G Di Perri, S Esser, et al.American Journal of Infection Control|December 1, 1989
Handwashing practices in an intensive care unit: the effects of an educational program and its relationship to infection ratesJ M Conly, S Hill, J Ross, et al.The Annals of Pharmacotherapy|March 1, 1993
Contamination study of multiple-dose vialsP S Melnyk, Y M Shevchuk, J M Conly, et al.JAMA|July 3, 1996
Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study GroupS L Sacks, F Y Aoki, F Diaz-Mitoma, et al.Antimicrobial Agents and Chemotherapy|August 1, 1989
Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinationsA W Chow, J Wong, K H Bartlett, et al.JAMA|September 18, 1998
Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research GroupF Diaz-Mitoma, R G Sibbald, S D Shafran, et al.The Journal of Infectious Diseases|August 1, 1984
Hypoprothrombinemia in febrile, neutropenic patients with cancer: association with antimicrobial suppression of intestinal microfloraJ M Conly, K Ramotar, H Chubb, et al.The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|February 21, 2012
Double-blind prospective randomized study comparing topical mupirocin and placebo for the prevention of infection associated with central venous cathetersJ M Conly, R Rennie, L Tan, et al.Pageof 8